Pfizer : PFE

All Pfizer Articles

1533 Articles

Lee Jackson | Dec 16, 2020 at 8:59 AM EST

Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Exxon, GE, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto, Pfizer, Twitter and More

Wednesday's top analyst upgrades and downgrades included Chipotle Mexican Grill, Etsy, Exxon Mobil, General Electric, Jazz Pharmaceuticals, Microsoft, Nikola, Palo…

Chris Lange | Dec 15, 2020 at 11:21 AM EST

Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock

BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.

Lee Jackson | Dec 10, 2020 at 9:50 AM EST

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may…

Chris Lange | Dec 2, 2020 at 11:55 AM EST

COVID-19 Vaccines Are on the Way and Major Players Are Cashing In

COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.

Chris Lange | Nov 23, 2020 at 11:18 AM EST

With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?

Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and…

Chris Lange | Nov 18, 2020 at 10:56 AM EST

Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial

Shares of COVID-19 vaccine duo Pfizer and BioNTech made handy gains on Wednesday after they announced their late-stage coronavirus study…

Jon C. Ogg | Nov 17, 2020 at 6:49 AM EST

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.

Paul Ausick | Nov 16, 2020 at 9:39 AM EST

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90%…

Jon C. Ogg | Nov 10, 2020 at 8:59 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon,…

Chris Lange | Nov 9, 2020 at 9:45 AM EST

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.

Jon C. Ogg | Oct 28, 2020 at 7:01 PM EDT

Did Regeneron Just Revive Hopes About Beating COVID-19?

The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in…

Jon C. Ogg | Oct 28, 2020 at 8:56 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft,…

Chris Lange | Oct 27, 2020 at 10:49 AM EDT

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday, and investors were not thrilled about…

Chris Lange | Oct 25, 2020 at 6:10 AM EDT

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

This week will be perhaps the biggest week of earnings season, with many major names reporting, including Amazon, Facebook, Ford…

Chris Lange | Oct 16, 2020 at 10:46 AM EDT

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s…

1 … 22 23 24 25 26 … 103

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Exxon, GE, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto, Pfizer, Twitter and More

Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

COVID-19 Vaccines Are on the Way and Major Players Are Cashing In

With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?

Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Did Regeneron Just Revive Hopes About Beating COVID-19?

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Exxon, GE, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto, Pfizer, Twitter and More

Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

COVID-19 Vaccines Are on the Way and Major Players Are Cashing In

With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?

Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Did Regeneron Just Revive Hopes About Beating COVID-19?

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Featured Reads

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.